Key result
Loop diuretics linked to ~110% higher risk of hypokalemia in heart failure.
Why the study?
Hypokalemia is a frequent and clinically important electrolyte disturbance in heart failure patients on diuretic therapy, but its occurrence and predictors need evaluation.
Cross-Sectional (n=150)
No
Hypokalemia is highly prevalent (31.3%) among hospitalized heart failure patients on diuretics, with high-dose and loop diuretics being significant independent predictors.
Answers are grounded in this paper and cite their sources.
May warrant closer K+ monitoring in HF on loop diuretics; hypothesis-generating and needs prospective confirmation.
BACKGROUND: Hypokalemia is one of the frequent and clinically important electrolyte disturbances in patients with heart failure (HF), especially among patients under diuretic treatment. The objective of this study was to evaluate the occurrence of hypokalemia and determine clinical predictors of this condition in patients with HF hospitalized on diuretics. METHODS: A cross-sectional study was conducted on 150 patients with HF in a hospital. Patients who were taking loop or thiazide diuretics for at least one week were included. The participants were divided into the hypokalemic (K < 3.5 mmol/L, n = 47) and normokalemic (K ≥ 3.5 mmol/L, n = 103) groups, based on serum potassium. The demographics, comorbidities, type and dose of diuretic, and other clinical variables were also collected. An automated ion-selective electrode analyzer was utilized to determine the concentration of potassium. SPSS 26.0 (IBM Corp., Armonk, NY, US) was used for data analysis with the p-value < 0.05 as significant. RESULTS: The prevalence of hypokalemia in the study population was 47 (31.3%). It strongly correlated with the use of loop diuretics (34 (72.3%) vs. 54 (52.4%), p = 0.042), high-dose diuretics (23 (48.9%) vs. 30 (29.1%), p = 0.015), and the presence of diabetes mellitus (18 (38.3%) vs. 23 (22.3%), p = 0.028). Loop diuretic use (odds ratio (OR) = 2.10, p = 0.023) and its high dose (OR = 1.80, p = 0.018) were the independent predictors of hypokalemia by logistic regression analysis. CONCLUSION: The study demonstrated that hypokalemia was common among HF patients receiving diuretic therapy, particularly loop diuretics in high doses. Although loop diuretic use and higher doses were significant independent predictors, the efficacy of interventions like dose adjustment or potassium-sparing drugs needs to be further validated in future randomized controlled trials.
No takes yet. Share an insight, caveat, or question.
Qaisar et al. (2025) conducted a cross-sectional in Heart failure (n=150). Loop diuretics vs. Thiazide diuretics was evaluated on Hypokalemia (serum potassium < 3.5 mmol/L) (OR 2.10, 95% CI 1.10-4.00, p=0.023). Loop diuretic use independently predicted a higher risk of hypokalemia in patients with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: